Use of Patient-reported Outcome Measures and Patient-reported Experience Measures within Evaluation Studies of Telemedicine Applications: Systematic Review (Preprint)

2021 ◽  
Author(s):  
Andreas Knapp ◽  
Lorenz Harst ◽  
Stefan Hager ◽  
Jochen Schmitt ◽  
Madlen Scheibe

BACKGROUND With the rise of digital health technologies and telemedicine services, the need for evidence-based evaluation is growing. Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are recommended as an essential part of comprehensive and multidisciplinary evaluation studies on telemedicine applications. For the first time, a systematic review has been conducted investigating the use of PROMs and PREMs in evaluation studies of telemedicine applications covering all application types and medical purposes. OBJECTIVE Our review investigates the following research questions: • In which scenarios were PROMs and PREMs collected for evaluation purposes? • Which PROM/PREM outcome domains have been covered and how often? • Which outcome measurement instruments (OMIs) have been used and how often? • Did the selection and quantity of PROMs and PREMs differ between study types and application types? • Has the use of PROMs and PREMs in evaluation studies changed over time? METHODS We conducted a systematic literature search in the MEDLINE and EMBASE databases and included studies published from inception until April 2, 2020. We included studies evaluating telemedicine applications with patients as main users; these studies reported PROMs and PREMs within randomized controlled trials (RCT), controlled trials, non-controlled trials and feasibility trials in English and German. RESULTS Out of 2671 records identified, 303 studies were included with 22.1% (67/303) feasibility studies, 23.1% (70/303) non-controlled trials, 6.6% (20/303) controlled trials and 48.2% (146/303) RCTs. Health-related quality of life (n=307, mean=1.0, SD=1.04), emotional function (n=244, mean=0.81, SD=1.18) and adherence (n=103, mean=0.34, SD=0.53) were the most frequently assessed outcome domains. 21.4% (65/303) of all studies used self-developed PROMs and 22.3% (68/303) self-developed PREMs. PROMs (n=884) were assessed more frequently than PREMs (n=234). As the evidence level of the studies increased, the number of PROMs also increased (τ=-0.45) with the number of PREMs decreasing (τ=0.35) at the same time. Since 2000, not only has the number of evaluation studies using PROMs/PREMs increased – the level of evidence and the number of OMIs used have also increased, with the number of PREMs permanently remaining at a lower level compared to the number of PROMs. CONCLUSIONS There have been increasingly more studies, particularly high-evidence studies, which use PROMs and PREMs to evaluate telemedicine applications. PROMs have been used more frequently than PREMs. With an increasing maturity stage of the telemedicine applications and higher evidence level, the use of PROMs increased in line with the recommendations of evaluation guidelines. Health-related quality of life (HRQoL) and emotional function were measured in almost all studies whereas health literacy as a critical precondition for using the application properly to gain health benefits was rarely reported. Therefore, further efforts should be pursued for the standardization of PROM and PREM collection in evaluation studies of telemedicine applications.

2021 ◽  
Vol 264 ◽  
pp. 394-401
Author(s):  
Mary Kate Luddy ◽  
Rachel Vetter ◽  
Jessica Shank ◽  
Whitney Goldner ◽  
Anery Patel ◽  
...  

2020 ◽  
pp. 089686082095996
Author(s):  
Fredric O Finkelstein ◽  
Monica Cimini ◽  
Susan H Finkelstein ◽  
Alan S Kliger

This study was designed as a pilot study to see whether electronic patient-reported outcome measures using computer adaptive technology (CAT) could be successfully implemented in clinics caring for chronic kidney disease (CKD) and peritoneal dialysis (PD) patients. The results demonstrate the feasibility of using CAT on an iPad to assess the symptom burden and health-related quality of life of both PD and CKD patients.


Author(s):  
Justyna Młyńczyk ◽  
Paweł Abramowicz ◽  
Maciej K. Stawicki ◽  
Jerzy Konstantynowicz

AbstractJuvenile idiopathic arthritis (JIA), as a chronic condition, is associated with symptoms negatively impacting health-related quality of life (HRQL). Regarding growing interest in the implementation of the patient-reported outcome measures (PROMs), we aimed to review the non-disease specific PROMs addressing HRQL assessment, potentially useful in the clinical care of JIA and daily practice. A systematic literature search was conducted using MEDLINE/PubMed, Google Scholar, Scopus and Embase databases (1990 to 2021), with a focus on the recent 5-years period. Entry keywords included the terms: “children”, “adolescents”, “JIA”, “chronic diseases”, “HRQL”, “PROMs” and wordings for the specific tools. Several available PROMs intended to measure HRQL, non-specific to JIA, were identified. The presented outcomes differed in psychometric properties, yet all were feasible in assessing HRQL in healthy children and those with chronic diseases. Both EQ-5D-Y and PedsQL have already been tested in JIA, showing relevant reliability, validity, and similar efficiency as disease-specific measurements. For PROMIS® PGH-7 and PGH-7 + 2, such validation and cross-cultural adaptation need to be performed. Considering the future directions in pediatric rheumatology, the large-scale implementation of PROMIS® PGH-7 and PGH-7 + 2 in JIA offers a particularly valuable opportunity. The PROMs reflect the patient perception of the chronic disease and allow to understand child’s opinions. The PROMs may provide an important element of the holistic medical care of patients with JIA and a standardized tool for clinical outcomes, monitoring disease severity and response to treatment.


Sign in / Sign up

Export Citation Format

Share Document